Serum endostatin level as a marker for coronary artery calcification in type 2 diabetic patients
| Autor: | Azza M. Ahmed, Zizi Saad, Hazem M. El-Ashmawy, Hisham Samir Roshdy |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
lcsh:Diseases of the circulatory (Cardiovascular) system
medicine.medical_specialty endocrine system diseases business.industry nutritional and metabolic diseases 030204 cardiovascular system & hematology medicine.disease Gastroenterology Coronary heart disease Confidence interval Spiral computed tomography Coronary artery disease 03 medical and health sciences 0302 clinical medicine lcsh:RC666-701 Internal medicine Coronary artery calcification medicine Original Article 030212 general & internal medicine Endostatin Agatston score business |
| Zdroj: | Journal of the Saudi Heart Association, Vol 31, Iss 1, Pp 24-31 (2019) |
| ISSN: | 1016-7315 |
| Popis: | Objective: To assess the relationship between serum endostatin (ES) and coronary artery calcification (CAC) in type 2 diabetic (T2DM) patients. Methods: The study included 110 participants with coronary artery disease (CAD); 55 with T2DM, for serum ES levels by enzyme-linked immunosorbent assay and CAC by contrast-enhanced spiral computed tomography (CT). Results: Mean serum ES value was 66.54 ng/mL [95% confidence interval (CI), 61.77–71.32 ng/mL]. Serum ES levels positively correlated with Agatston score index [ASI; r = 0.701, p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|